Our Medical Team
Specialists in HSCT Autologous Stem Cell Transplantation for MS and other Autoimmune Conditions.
Meet the specialists behind India’s most trusted HSCT programme. Our multidisciplinary team brings together world-class expertise in stem cell transplantation, haematology, infectious disease and neurology — united by a single mission: delivering safe, effective and affordable HSCT care to patients from India and across the world.
Dr. Rahul Bhargava
MBBS, MD (Medicine), DM (Clinical Haematology, AIIMS) | Fellowship SCT, Vancouver Canada
A pioneering Indian haematologist and haemato-oncologist, Dr. Bhargava with impeccable track record of performing the largest number for HSCT for Multiple Sclerosis with excellent outcomes. His team is among the largest and most successful for both adult and paediatric stem cell transplants. His empathetic, patient-centric approach and use of cutting-edge technology have firmly established his reputation as a leader in the field. He has established 14 low-cost BMT centres across India, bringing world-class transplantation care to underserved communities.
DM, AIIMS New Delhi + Advanced Fellowship in unrelated & Haploidentical transplant, Vancouver, Canada
Best BMT Surgeon — MTI Indian Medical Tourism Summit 2020
Matched sibling transplants | Haploidentical transplants | Unrelated donor transplants | Haemato-oncology | Molecular haematology | Benign haematology
Dr. Saurabh Bansal
MBBS, MD (Medicine), DM (Neurology)
A highly decorated neurologist with specialised training in movement disorders across Canada and India, A critical member of the HSCT India team, he evaluates and co-manages patients with Multiple Sclerosis (MS), CIDP, Myasthenia Gravis and small fibre neuropathy being considered for stem cell transplantation — ensuring each candidate is carefully assessed for the best possible outcomes Dr. Bansal brings deep expertise in management of Autoimmune conditions like Multiple Sclerosis, Small fibre Neuropathy, Myasthenia Gravis. He also is an expert on neuromuscular disease management with Deep Brain Stimulation. He has multiple publications in indexed national and international journals. He was awarded a research grant in 2022 to present at the International MDS Meet in Madrid, and He is committed to advancing specialist neurology care across the region.
Movement Disorders, UWO Canada + DBS Academy, Toronto Western Hospital, 2022
First Prize — Neurology Quiz, IANCON 2014; First Prize — EEG Quiz, Hyderabad 2017
Autoimmune Disease Specialist – Multiple Sclerosis, Small Fiber Neuropathy, CIDP, Myasthenia Gravis| Deep Brain Stimulation | Movement disorders | Parkinson’s disease | Epilepsy & VEEG | Chronic migraine | Botulinum toxin | Acute stroke management | Neuromuscular disorders
Dr. Neha Rastogi Panda
With over 10 years of specialist experience, Dr. Neha Rastogi Panda is a leading authority in infectious disease management — including transplant-related, cancer-related, and complex fungal infections. She was instrumental in formulating COVID and Hand Hygiene policies at AIIMS Delhi and has collaborated with the US Centers for Disease Control and Prevention (CDC) on infection prevention, control, and device-associated infections. She has also contributed to antimicrobial guidelines and app-based antimicrobial stewardship.
COVID & Hand Hygiene policy formulation, AIIMS Delhi
CDC (US) — infection prevention & device-associated infections
•Management of Transplant-related infections and febrile neutropenia.| Difficult fungal infections | Drug-resistant TB | HIV & tropical infections | Antimicrobial stewardship | Travel health & vaccines | Neurosurgical infections | COVID-19 & sequelae
Why Choose HSCT Hospital India for Your Long-Term MS Treatment
The research is clear: outcomes are best at high-volume, accredited centres with experienced transplant teams. Clinical outcomes are strongly linked to experience and facility standards. HSCT Hospital India has been delivering HSCT for MS since 2016 at #1 JCI-USA accredited World Class Hospital In India .
- Treatment based on the Dr. Richard Burt non-myeloablative protocol— Burt — the same protocol that produced the landmark JAMA trial results.
- JCI-USA Accredited, NABH & NABL certified — the highest standards of patient safety and clinical governance.
- 1,500+ patients treated from over 30 countries across Europe, North America, and Australia. Watch video testimonials Click here
- All-inclusive 30-day in-hospital package at $30,000 USD — the most transparent and affordable pricing of any accredited HSCT centre globally. Check out HSCT package details Click here
- HEPA-filtered private rooms with triple-level air filtration — no outside hospital stays, eliminating infection risk during the critical engraftment phase.
JCI-USA Accredited, NABH & NABL certified — the highest standards of patient safety and clinical governance.
All-inclusive 30-day in-hospital package at $30,000 USD — the most transparent and affordable pricing of any accredited HSCT centre globally. 
